{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:39:07Z","timestamp":1794573547051,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CSL Behring"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0923-8","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T12:26:03Z","timestamp":1542025563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and management"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-5570","authenticated-orcid":false,"given":"Pere","family":"Soler-Palac\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ignacio","family":"Gonz\u00e1lez-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodr\u00edguez-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez-Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung ID-Signal","family":"Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"923_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1365-2249.2011.04461.x","volume":"167","author":"E de Vries","year":"2012","unstructured":"de Vries E. European Society for Immunodeficiencies m. patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167:108\u201319.","journal-title":"Clin Exp Immunol"},{"key":"923_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96\u2013128.","journal-title":"J Clin Immunol"},{"key":"923_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10875-013-9954-6","volume":"34","author":"BT Costa-Carvalho","year":"2014","unstructured":"Costa-Carvalho BT, Grumach AS, Franco JL, et al. Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice. J Clin Immunol. 2014;34:10\u201322.","journal-title":"J Clin Immunol"},{"key":"923_CR4","first-page":"25","volume":"1","author":"N Mahlaoui","year":"2014","unstructured":"Mahlaoui N, Gathmann B, Kindle G, Ehl S. ESID registry working party steering committee, ESID society. The European Society for Immunodeficiencies (ESID) registry: recent advancements in the epidemiology of primary Immunodeficiencies and how does that translate in clinical care. Int J Public Health. 2014;1:25\u20137.","journal-title":"Int J Public Health"},{"key":"923_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","volume":"33","author":"AA Bousfiha","year":"2013","unstructured":"Bousfiha AA, Jeddane L, Ailal F, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33:1\u20137.","journal-title":"J Clin Immunol"},{"issue":"8","key":"923_CR6","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","volume":"34","author":"Lisa Kobrynski","year":"2014","unstructured":"Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007. J Clin Immunol. 2014;34:954\u201361.","journal-title":"Journal of Clinical Immunology"},{"key":"923_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/clim.2002.5241","volume":"104","author":"A Plebani","year":"2002","unstructured":"Plebani A, Soresina A, Rondelli R, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104:221\u201330.","journal-title":"Clin Immunol"},{"key":"923_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12026-011-8241-y","volume":"51","author":"V Modell","year":"2011","unstructured":"Modell V, Gee B, Lewis DB, et al. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61\u201370.","journal-title":"Immunol Res"},{"key":"923_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1590\/S1806-37132009001000010","volume":"35","author":"P Roxo Junior","year":"2009","unstructured":"Roxo Junior P. Primary immunodeficiency diseases: relevant aspects for pulmonologists. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2009;35:1008\u201317.","journal-title":"Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia"},{"key":"923_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fped.2014.00077","volume":"2","author":"M Jesenak","year":"2014","unstructured":"Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr. 2014;2:77.","journal-title":"Front Pediatr"},{"key":"923_CR11","unstructured":"Jeffrey Modell Foundation. 10 Warning Signs of Primary Immunodeficiency for Adults. Disponible en: \n                    http:\/\/www.info4pi.org\/aboutPI\/pdf\/Adult10WarningSigns-FINAL.pdf\n                    \n                  ."},{"key":"923_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.2011.06206.x","volume":"1238","author":"PD Arkwright","year":"2011","unstructured":"Arkwright PD, Gennery AR. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann N Y Acad Sci. 2011;1238:7\u201314.","journal-title":"Ann N Y Acad Sci"},{"key":"923_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1542\/peds.2010-3680","volume":"127","author":"A Subbarayan","year":"2011","unstructured":"Subbarayan A, Colarusso G, Hughes SM, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011;127:810\u20136.","journal-title":"Pediatrics"},{"key":"923_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.crad.2011.10.028","volume":"67","author":"FA Hampson","year":"2012","unstructured":"Hampson FA, Chandra A, Screaton NJ, et al. Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders. Clin Radiol. 2012;67:587\u201395.","journal-title":"Clin Radiol"},{"key":"923_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S2213-2600(15)00202-7","volume":"3","author":"N Verma","year":"2015","unstructured":"Verma N, Grimbacher B, Hurst JR. Lung disease in primary antibody deficiency. Lancet Respir Med. 2015;3:651\u201360.","journal-title":"Lancet Respir Med"},{"key":"923_CR16","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3389\/fimmu.2018.01837","volume":"9","author":"U Baumann","year":"2018","unstructured":"Baumann U, Routes JM, Soler-Palac\u00edn P, Jolles S. The lung in primary Immunodeficiencies: new concepts in infection and inflammation. Front Immunol. 2018;9:1837.","journal-title":"Front Immunol"},{"key":"923_CR17","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1378\/chest.10-3147","volume":"140","author":"G Serra","year":"2011","unstructured":"Serra G, Milito C, Mitrevski M, et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest. 2011;140:1581\u20139.","journal-title":"Chest"},{"key":"923_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/CMR.00001-09","volume":"22","author":"AJ Fried","year":"2009","unstructured":"Fried AJ, Bonilla FA. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev. 2009;22:396\u2013414.","journal-title":"Clin Microbiol Rev"},{"key":"923_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.iac.2015.07.004","volume":"35","author":"S Nonas","year":"2015","unstructured":"Nonas S. Pulmonary manifestations of primary immunodeficiency disorders. Immunol Allergy Clin N Am. 2015;35:753\u201366.","journal-title":"Immunol Allergy Clin N Am"},{"key":"923_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archdermatol.2011.262","volume":"148","author":"EY Chu","year":"2012","unstructured":"Chu EY, Freeman AF, Jing H, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol. 2012;148:79\u201384.","journal-title":"Arch Dermatol"},{"key":"923_CR21","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","volume":"361","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046\u201355.","journal-title":"N Engl J Med"},{"key":"923_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1525-1470.2011.01409.x","volume":"28","author":"W Al-Herz","year":"2011","unstructured":"Al-Herz W, Nanda A. Skin manifestations in primary immunodeficient children. Pediatr Dermatol. 2011;28:494\u2013501.","journal-title":"Pediatr Dermatol"},{"key":"923_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clim.2011.01.008","volume":"139","author":"LJ Kobrynski","year":"2011","unstructured":"Kobrynski LJ, Mayer L. Diagnosis and treatment of primary immunodeficiency disease in patients with gastrointestinal symptoms. Clin Immunol. 2011;139:238\u201348.","journal-title":"Clin Immunol"},{"key":"923_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2249.2011.04388.x","volume":"164","author":"C. Cunningham-Rundles","year":"2011","unstructured":"Cunningham-Rundles C. Autoimmunity in primary immune deficiency: taking lessons from our patients. Clin Exp Immunol 2011;164 Suppl 2:6\u201311.","journal-title":"Clinical & Experimental Immunology"},{"issue":"Suppl 1","key":"923_CR25","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1007\/s10875-008-9176-5","volume":"28","author":"D Moraes-Vasconcelos","year":"2008","unstructured":"Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR, Ochs HD. Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol. 2008;28(Suppl 1):S11\u20139.","journal-title":"J Clin Immunol"},{"key":"923_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-3083.2010.02386.x","volume":"71","author":"GJ Arason","year":"2010","unstructured":"Arason GJ, Jorgensen GH, Ludviksson BR. Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol. 2010;71:317\u201328.","journal-title":"Scand J Immunol"},{"key":"923_CR27","unstructured":"Warning signs of Primary Immunodeficiency for specialty care physicians. (Accessed Sept.-19-2018, at \n                    http:\/\/downloads.info4pi.org\/pdfs\/Diagnostic-Algorithm-for-Specialty-Care-Physicians.pdf\n                    \n                  .)"},{"key":"923_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/cei.12369","volume":"177","author":"S Jolles","year":"2014","unstructured":"Jolles S, Borrell R, Zouwail S, et al. Calculated globulin (CG) as a screening test for antibody deficiency. Clin Exp Immunol. 2014;177:671\u20138.","journal-title":"Clin Exp Immunol"},{"key":"923_CR29","doi-asserted-by":"crossref","unstructured":"Pecoraro A, Jolles S, Crescenzi L, et al. Validation of calculated globulin (CG) as a screening test for antibody deficiency in an Italian University hospital. Curr Pharm Biotechnol. 2018.","DOI":"10.2174\/1389201019666180808163311"},{"issue":"6","key":"923_CR30","doi-asserted-by":"publisher","first-page":"e22420","DOI":"10.1002\/jcla.22420","volume":"32","author":"Marina Garcia-Prat","year":"2018","unstructured":"Garcia-Prat M, Vila-Pijoan G, Martos Gutierrez S, et al. Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the Optilite. J Clin Lab Anal. 2018:e22420.","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"923_CR31","first-page":"16","volume":"112","author":"L Ozerovitch","year":"2016","unstructured":"Ozerovitch L. Primary immune deficiency in bronchiectasis. Nurs Times. 2016;112:16\u20139.","journal-title":"Nurs Times"},{"key":"923_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/qjmed\/95.10.655","volume":"95","author":"KM Thickett","year":"2002","unstructured":"Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM. 2002;95:655\u201362.","journal-title":"QJM"},{"key":"923_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.medcli.2009.06.050","volume":"134","author":"A Sala Cunill","year":"2010","unstructured":"Sala Cunill A, Soler-Palac\u00edn P, Mart\u00edn De Vicente C, Labrador Horrillo M, Luengo S\u00e1nchez O, Figueras Nadal C. Common variable immunodeficiency. Prognostic factors for lung damage Med Clin (Barc). 2010;134:64\u20137.","journal-title":"Prognostic factors for lung damage Med Clin (Barc)"},{"key":"923_CR34","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","volume":"139","author":"EE Perez","year":"2017","unstructured":"Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017;139:S1\u2013s46.","journal-title":"J Allergy Clin Immunol"},{"key":"923_CR35","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650\u20137.","journal-title":"Blood"},{"issue":"Suppl 1","key":"923_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cei.12516","volume":"178","author":"S Jolles","year":"2014","unstructured":"Jolles S. Subclinical infection and dosing in primary immunodeficiencies. Clin Exp Immunol. 2014;178(Suppl 1):67\u20139.","journal-title":"Clin Exp Immunol"},{"key":"923_CR37","first-page":"185","volume":"57","author":"ER Stiehm","year":"2010","unstructured":"Stiehm ER, Orange JS, Ballow M, Lehman H. Therapeutic use of immunoglobulins. Adv Pediatr Infect Dis. 2010;57:185\u2013218.","journal-title":"Adv Pediatr Infect Dis"},{"issue":"6","key":"923_CR38","doi-asserted-by":"publisher","first-page":"1354-1360.e4","DOI":"10.1016\/j.jaci.2010.02.040","volume":"125","author":"Mary Lucas","year":"2010","unstructured":"Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010;125:1354\u20131360 e4.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"923_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2217\/imt.14.34","volume":"6","author":"RL Wasserman","year":"2014","unstructured":"Wasserman RL. Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies. Immunotherapy. 2014;6:553\u201367.","journal-title":"Immunotherapy"},{"key":"923_CR40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.iac.2008.07.002","volume":"28","author":"M Berger","year":"2008","unstructured":"Berger M. Subcutaneous administration of IgG. Immunol Allergy Clin N Am. 2008;28:779\u2013802 viii.","journal-title":"Immunol Allergy Clin N Am"},{"key":"923_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00063030-200721020-00005","volume":"21","author":"A Gardulf","year":"2007","unstructured":"Gardulf A. Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route. BioDrugs. 2007;21:105\u201316.","journal-title":"BioDrugs"},{"key":"923_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.transci.2012.03.022","volume":"46","author":"\u00c9 Haddad","year":"2012","unstructured":"Haddad \u00c9, Barnes D, Kafal A. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases. Transfus Apher Sci. 2012;46:315\u201321.","journal-title":"Transfus Apher Sci"},{"key":"923_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/adc.79.1.48","volume":"79","author":"J Gaspar","year":"1998","unstructured":"Gaspar J, Gerritsen B, Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child. 1998;79:48\u201351.","journal-title":"Arch Dis Child"},{"key":"923_CR44","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s10875-010-9417-2","volume":"30","author":"S Th\u00e9pot","year":"2010","unstructured":"Th\u00e9pot S, Malphettes M, Gardeur A, et al. Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels. J Clin Immunol. 2010;30:602\u20136.","journal-title":"J Clin Immunol"},{"key":"923_CR45","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s40265-013-0094-3","volume":"73","author":"J Lingman-Framme","year":"2013","unstructured":"Lingman-Framme J, Fasth A. Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review. Drugs. 2013;73:1307\u201319.","journal-title":"Drugs"},{"key":"923_CR46","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/SMJ.0b013e3181eba6ea","volume":"103","author":"M Berger","year":"2010","unstructured":"Berger M, Murphy E, Riley P, Bergman GE, Investigators VT. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. South Med J. 2010;103:856\u201363.","journal-title":"South Med J"},{"key":"923_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10875-006-9002-x","volume":"26","author":"A Gardulf","year":"2006","unstructured":"Gardulf A, Nicolay U, Asensio O, et al. Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study. J Clin Immunol. 2006;26:177\u201385.","journal-title":"J Clin Immunol"},{"key":"923_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13223-015-0092-y","volume":"11","author":"F Jiang","year":"2015","unstructured":"Jiang F, Torgerson TR, Ayars AG. Health-related quality of life in patients with primary immunodeficiency disease. Allergy Asthma Clin Immunol. 2015;11:27.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"923_CR49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/cei.12485","volume":"179","author":"S Jolles","year":"2015","unstructured":"Jolles S, Orange JS, Gardulf A, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179:146\u201360.","journal-title":"Clin Exp Immunol"},{"key":"923_CR50","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jaci.2004.06.053","volume":"114","author":"A Gardulf","year":"2004","unstructured":"Gardulf A, Nicolay U, Math D, et al. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol. 2004;114:936\u201342.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"923_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2249.2009.04027.x","volume":"158","author":"S Misbah","year":"2009","unstructured":"Misbah S, Sturzenegger MH, Borte M, et al. Subcutaneous immunoglobulin: opportunities and outlook. Clin Exp Immunol. 2009;158(Suppl 1):51\u20139.","journal-title":"Clin Exp Immunol"},{"key":"923_CR52","first-page":"831","volume":"11","author":"A Bourdin","year":"2015","unstructured":"Bourdin A, Berger J, Fr\u00fch A, Spertini F, Bugnon O. Subcutaneous immunoglobulin and support program: what level of interest of patients? Rev Med Suisse. 2015;11:831\u20135.","journal-title":"Rev Med Suisse"},{"key":"923_CR53","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10875-014-0096-2","volume":"34","author":"P Soler-Palac\u00edn","year":"2014","unstructured":"Soler-Palac\u00edn P, Gas\u00f3-Gago I, Fern\u00e1ndez-Polo A, et al. Intravenous and subcutaneous immunoglobulin replacement: a two-way road. Optimizing healthcare quality in patients with primary immunodeficiencies. J Clin Immunol. 2014;34:1015\u20137.","journal-title":"J Clin Immunol"},{"key":"923_CR54","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jaci.2007.07.044","volume":"120","author":"J Chinen","year":"2007","unstructured":"Chinen J, Anmuth D, Franklin AR, Shearer WT. Long-term follow-up of patients with primary immunodeficiencies. J Allergy Clin Immunol. 2007;120:795\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"923_CR55","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","volume":"94","author":"FA Bonilla","year":"2005","unstructured":"Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94:S1\u201363.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"923_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2249.2008.03851.x","volume":"155","author":"M. D. Tarzi","year":"2009","unstructured":"Tarzi MD, Grigoriadou S, Carr SB, Kuitert LM, Longhurst HJ. Clinical immunology review series: an approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunol. 2009;155:147\u201355.","journal-title":"Clinical & Experimental Immunology"},{"issue":"2","key":"923_CR57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/cei.13012","volume":"190","author":"S. Jolles","year":"2017","unstructured":"Jolles S, S\u00e1nchez-Ram\u00f3n S, Quinti I, et al. Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group. Clin Exp Immunol. 2017;190:226\u201334.","journal-title":"Clinical & Experimental Immunology"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0923-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T11:18:34Z","timestamp":1589973514000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0923-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0923-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"16 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"219"}}